greeksoup/ stock research
Stock research / United States / ELAN / FY2016

Elanco Animal Health (ELAN) FY2016 results: revenue $2.9 billion

Elanco Animal Health Inc. (ELAN) reported revenue of $2.9 billion for fiscal 2016, the year ended 31 December 2016. Net income was -$48 million, and diluted earnings per share $-0.16. The figures are the company's own, from the 10-K it filed with the SEC on 20 February 2019.

Revenue
$2.9 billion
FY2016FY2016
Operating margin
-0.8%
FY2016FY2016
Net income
-$48 million
FY2016FY2016
Diluted EPS
-$0.16
FY2016FY2016

this yearthe year beforeHover a bar for its figure.

The year in brief

Income statement (profit and loss)

$ millionFY2016Last 8 years
Revenue2,914
Cost of revenue1,409
Gross profit1,504
Gross margin51.6%
Research and development266
Selling, general and administrative785
Operating income-22.4
Operating margin-0.8%
Interest expense0.0
Pre-tax income-22.4
Income tax25.5
Net income-47.9
Net margin-1.6%
Diluted EPS-$0.16
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2016Last 8 years
Operating cash flow156
Capital expenditure110
Free cash flow45.6
Free cash flow margin1.6%
Cash from investing-182
Cash from financing-150
Depreciation and amortisation254
Share-based compensation20.4
Diluted shares, weighted293m

Balance sheet

$ millionFY2016Last 8 years
Shareholders' equity7,017
Cash and equivalents259

10-K for the year ended 31 December 2016, filed 20 February 2019: the filing.